CD4+CD25+ Regulatory T Cells Reverse Established Allergic Airway Inflammation and Prevent Airway Remodeling

Overview

Journal J Allergy Clin Immunol

Specialty Allergy & Immunology

Date 2008 Aug 2

PMID 18672278

Citations 73

Authors

Jennifer Kearley

Douglas S Robinson

Clare M Lloyd

Affiliations

Soon will be listed here.

Abstract

Background: CD4(+)CD25(+) regulatory T cells can inhibit excessive T-cell responses in vivo. We have previously demonstrated that prophylactic administration of CD4(+)CD25(+) regulatory T cells suppresses the development of acute allergen-induced airway inflammation in vivo.

Objective: We sought to determine the effect of therapeutic transfer of CD4(+)CD25(+) regulatory T cells on established pulmonary inflammation and the subsequent development of airway remodeling.

Methods: CD4(+)CD25(+) cells were transferred after the onset of allergic inflammation, and airway challenges were continued to induce chronic inflammation and airway remodeling.

Results: Administration of CD4(+)CD25(+) regulatory T cells reduced established lung eosinophilia, T(H)2 infiltration, and expression of IL-5, IL-13, and TGF-beta. Moreover, subsequent mucus hypersecretion and peribronchial collagen deposition were reduced after prolonged challenge. In contrast, transfer of CD4(+)CD25(+) regulatory T cells had no effect on established airway hyperreactivity either 7 days or 4 weeks after transfer.

Conclusions: In this study we demonstrate for the first time that therapeutic transfer of CD4(+)CD25(+) regulatory T cells can resolve features of chronic allergen-induced inflammation and prevent development of airway remodeling.

Citing Articles

Intranasal Immunization of Pneumococcal Mutant Attenuates Allergic and Inflammatory Diseases by Upregulating Skin and Mucosal Tregs.

Iqbal H, Rhee D Vaccines (Basel). 2024; 12(7).

PMID: 39066375 PMC: 11281725. DOI: 10.3390/vaccines12070737.

Immunological factors, important players in the development of asthma.

Wang Y, Liu L BMC Immunol. 2024; 25(1):50.

PMID: 39060923 PMC: 11282818. DOI: 10.1186/s12865-024-00644-w.

GM-CSF-dependent CD301b+ lung dendritic cells confer tolerance to inhaled allergens.

Wilkinson C, Nakano K, Grimm S, Whitehead G, Arao Y, Blackshear P Res Sq. 2024; .

PMID: 38883724 PMC: 11177951. DOI: 10.21203/rs.3.rs-4414130/v1.

Engineering nanoparticle therapeutics for food allergy.

Rad L, Arellano G, Podojil J, OKonek J, Shea L, Miller S J Allergy Clin Immunol. 2023; 153(3):549-559.

PMID: 37926124 PMC: 10939913. DOI: 10.1016/j.jaci.2023.10.013.

Suppression of airway allergic eosinophilia by Hp-TGM, a helminth mimic of TGF-β.

Chauche C, Rasid O, Donachie A, McManus C, Loser S, Campion T Immunology. 2022; 167(2):197-211.

PMID: 35758054 PMC: 9885513. DOI: 10.1111/imm.13528.

References

Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben T, Karp C . Interleukin-13: central mediator of allergic asthma. Science. 1998; 282(5397):2258-61. DOI: 10.1126/science.282.5397.2258. View

Leckie M, Ten Brinke A, Khan J, Diamant Z, OConnor B, Walls C . Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2001; 356(9248):2144-8. DOI: 10.1016/s0140-6736(00)03496-6. View

Ward C, Walters H . Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol. 2005; 5(1):43-8. DOI: 10.1097/00130832-200502000-00009. View

Powrie F, Carlino J, Leach M, Mauze S, Coffman R . A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996; 183(6):2669-74. PMC: 2192626. DOI: 10.1084/jem.183.6.2669. View

Lloyd C, Gonzalo J, Nguyen T, Delaney T, Tian J, Oettgen H . Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol. 2001; 166(3):2033-40. DOI: 10.4049/jimmunol.166.3.2033. View

Saglani S, Malmstrom K, Pelkonen A, Malmberg L, Lindahl H, Kajosaari M . Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med. 2005; 171(7):722-7. DOI: 10.1164/rccm.200410-1404OC. View

McMillan S, Xanthou G, Lloyd C . Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol. 2005; 174(9):5774-80. DOI: 10.4049/jimmunol.174.9.5774. View

Mottet C, Uhlig H, Powrie F . Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003; 170(8):3939-43. DOI: 10.4049/jimmunol.170.8.3939. View

Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig M . Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 2003; 112(7):1029-36. PMC: 198522. DOI: 10.1172/JCI17974. View

10.

Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F . Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001; 194(6):847-53. PMC: 2195967. DOI: 10.1084/jem.194.6.847. View

11.

Joetham A, Takeda K, Takada K, Taube C, Miyahara N, Matsubara S . Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol. 2007; 178(3):1433-42. DOI: 10.4049/jimmunol.178.3.1433. View

12.

Morgan M, Flierman R, van Duivenvoorde L, Witteveen H, van Ewijk W, van Laar J . Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 2005; 52(7):2212-21. DOI: 10.1002/art.21195. View

13.

Bousquet J, Jeffery P, Busse W, Johnson M, Vignola A . Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000; 161(5):1720-45. DOI: 10.1164/ajrccm.161.5.9903102. View

14.

Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes P, Robinson D . Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J. 2004; 24(1):122-8. DOI: 10.1183/09031936.04.00077803. View

15.

Humbles A, Lloyd C, McMillan S, Friend D, Xanthou G, McKenna E . A critical role for eosinophils in allergic airways remodeling. Science. 2004; 305(5691):1776-9. DOI: 10.1126/science.1100283. View

16.

Bonniaud P, Margetts P, Ask K, Flanders K, Gauldie J, Kolb M . TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol. 2005; 175(8):5390-5. DOI: 10.4049/jimmunol.175.8.5390. View

17.

Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M . Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003; 168(8):983-8. DOI: 10.1164/rccm.200211-1268OC. View

18.

Chatila T . Role of regulatory T cells in human diseases. J Allergy Clin Immunol. 2005; 116(5):949-59. DOI: 10.1016/j.jaci.2005.08.047. View

19.

Lewkowich I, Herman N, Schleifer K, Dance M, Chen B, Dienger K . CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med. 2005; 202(11):1549-61. PMC: 2213331. DOI: 10.1084/jem.20051506. View

20.

Grunig G, Warnock M, Wakil A, Venkayya R, Brombacher F, Rennick D . Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282(5397):2261-3. PMC: 3897229. DOI: 10.1126/science.282.5397.2261. View